The Northwick Park "functional" psychosis study: diagnosis and treatment response (Q51186898)

1 April 2018

title

The Northwick Park "functional" psychosis study: diagnosis and treatment response (English)

1 reference

1 April 2018

1 reference

3

C D Frith

1 reference

1 April 2018

1

E C Johnstone

1 reference

1 April 2018

author name string

T J Crow

series ordinal

2

1 reference

1 April 2018

D G Owens

series ordinal

4

1 reference

1 April 2018

language of work or name

English

0 references

publication date

1 July 1988

1 reference

1 April 2018

published in

The Lancet

1 reference

1 April 2018

volume

2

1 reference

1 April 2018

issue

8603

1 reference

1 April 2018

page(s)

119-125

1 reference

1 April 2018

Schizo-affective psychosis: definitions and incidence

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Schizo-affective psychosis: fact or fiction? A survey of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

The group of schizoaffective and related psychoses--critique, record, follow-up, and family studies. I. A persistent enigma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Efficacy of lithium as acute treatment of manic-depressive illness

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Lithium in the treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Trials of Lithium, Chlorpromazine and Amitriptyline in Schizoaffective Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Depressed patients with schizophrenic or paranoid symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

NORMOTHYMOTICS, "MOOD-NORMALIZERS": ARE LITHIUM AND THE IMIPRAMINE DRUGS SPECIFIC FOR AFFECTIVE DISORDERS?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Antipsychotic effects of lithium in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Lithium response in good prognosis schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

A comparison of lithium carbonate and chlorpromazine in the treatment of excited schizo-affectives. Report of the Veterans Administration and National Institute of Mental Health collaborative study group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

A placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Combination of lithium carbonate and haloperidol in schizo-affective disorder: a controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

A standardized psychiatric assessment scale for rating chronic psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Mechanism of the antipsychotic effect in the treatment of acute schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

The mania rating scale: scale construction and inter-observer agreement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

A New Depression Scale Designed to be Sensitive to Change

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Prevalence of tardive dyskinesia in an outpatient population.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Phenomenology of organic and functional psychoses and the overlap between them

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Pimozide in the treatment of newly admitted schizophrenic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Double-blind comparative clinical trial of pimozide and chlorpromazine in mania. A test of the dopamine hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Dopamine and mania: Behavioral and biochemical effects of the dopamine receptor blocker pimozide

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

1 reference

7 January 2021

Lithium Treatment in Schizophrenia and Schizo-Affective Disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Comparative Effects of Lithium and Chlorpromazine in the Treatment of Acute Manic States

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Lithium carbonate: a clinical study.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Mechanisms of lithium action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Lithium carbonate treatment of mania. Cerebrospinal fluid and urinary monoamine metabolites and treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

A cholinergic-adrenergic hypothesis of mania and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Cholinergic mechanisms in affective disorders. Future directions for investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

Therapeutic reversal with benxtropine in schizophrenics. Practical and theoretical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

The continuum of psychosis and its implication for the structure of the gene

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

The identification of disease entities and the relationship between schizophrenic and affective psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2888%2990682-4

7 January 2021

10.1016/S0140-6736(88)90682-4

Identifiers

DOI

1 reference

1 April 2018

1 reference

1 April 2018